Tracking cancer drugs in living cells by thermal profiling of the proteome
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Mapping human drug targets in the cell: To understand both the beneficial and the side effects of a drug, one would need to know its full binding profile to all cellular proteins. Savitski et al. take significant steps toward meeting this daunting challenge. They monitored the unfolding or “melting” of over 7000 human proteins and measured how small-molecule binding changes individual melting profiles. As a proof of principle, over 50 targets were identified for an inhibitor known to bind a broad spectrum of kinases. Two cancer drugs, vemurafib and Alectinib, are known to have a side effect of photosensitivity. The thermal profiling approach identified drug-protein interactions responsible for these side effects. Science , this issue 10.1126/science.1255784
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thermal proteome profiling (TPP, Savitski et al, 2014) is a mass-spectrometry (MS) based functional proteomics method that can identify shifts in protein thermal stability across different conditions (Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“Especially in combination with quantitative changes measured by e.g., phosphoproteomics, TPP can be used to identify functionally relevant alterations and link them to signaling and phenotypic consequences (Savitski et al, 2014; Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“TPP has been used successfully in the past for drug profiling, but it generates complex data that are difficult to interpret and potentially benefit from integration with other data types (Savitski et al, 2014; Perrin et al, 2020; Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“Thermal stabilization (i) is leveraged in thermal proteomics profiling (TPP), an approach that has been employed to, for instance, identify the ferrochelatase FECH as a frequent off-target of kinase inhibitors,224 or to uncover leucine aminopeptidase 3 as an off-target of several HDAC inhibitors.225”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [224]
In the citing paper
“This assay is based on the concept that binding of a compound to a protein can result in thermal stabilization of the protein and-consequently-in a detectable shift of its melting curve.”
From Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer (2021) · cites this paper as Savitski et al., 2014
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
Eden, E., Navon, R., Steinfeld, I., Lipson, D., & Yakhini, Z. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-48 · Cited by 3,356
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Self-citationDefinition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Bollag, G., Hirth, P., Tsai, J., Zhang, J., Ibrahim, P. N., Cho, H., Spevak, W., Zhang, C., Zhang, Y., Habets, G., et al. (2010) · Nature · doi:10.1038/nature09454 · Cited by 1,831
Mass-spectrometry-based draft of the human proteome
Wilhelm, M., Schlegl, J., Hahne, H., Gholami, A. M., Lieberenz, M., Savitski, M. M., Ziegler, E., Butzmann, L., Gessulat, S., Marx, H., et al. (2014) · Nature · doi:10.1038/nature13319 · Cited by 1,820
Self-citationOverriding Imatinib Resistance with a Novel ABL Kinase Inhibitor
Shah, N. P., Tran, C., Lee, F. Y., Chen, P., Norris, D., & Sawyers, C. L. (2004) · Science · doi:10.1126/science.1099480 · Cited by 1,796
Kulak, N. A., Pichler, G., Paron, I., Nagaraj, N., & Mann, M. (2014) · Nature Methods · doi:10.1038/nmeth.2834 · Cited by 1,719
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1328 · Cited by 1,034
Self-citation
Cited by
Items 101–200 of 1,004
High-throughput quantitative top-down proteomics
Cupp‐Sutton, K. A., & Wu, S. (2020) · Molecular Omics · doi:10.1039/c9mo00154a · Cited by 137
Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells
Page, B. D. G., Valerie, N. C. K., Wright, R. H. G., Wallner, O. A., Isaksson, R., Carter, M., Rudd, S. G., Loseva, O., Jemth, A., Almlöf, I., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02293-7 · Cited by 129
Functional interdependence of BRD4 and DOT1L in MLL leukemia
Gilan, O., Lam, E. Y. N., Becher, I., Lugo, D., Cannizzaro, E., Joberty, G., Ward, A., Wiese, M., Fong, C. Y., Ftouni, S., et al. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3249 · Cited by 123
Self-citationNanoparticle Surface Functionality Dictates Cellular and Systemic Toxicity
Saei, A. A., Yazdani, M., Lohse, S. E., Bakhtiary, Z., Serpooshan, V., Ghavami, M., Asadian, M., Mashaghi, S., Dreaden, E. C., Mashaghi, A., et al. (2017) · Chemistry of Materials · doi:10.1021/acs.chemmater.7b01979 · Cited by 121
Beckham, K. S. H., Ciccarelli, L., Bunduc, C. M., Mertens, H. D. T., Ummels, R., Lugmayr, W., Mayr, J., Rettel, M., Savitski, M. M., Svergun, D. I., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.47 · Cited by 112
Self-citationChemical Proteomics Reveals Ferrochelatase as a Common Off-target of Kinase Inhibitors
Klaeger, S., Gohlke, B., Perrin, J., Gupta, V., Heinzlmeir, S., Helm, D., Qiao, H., Bergamini, G., Handa, H., Savitski, M. M., et al. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b01063 · Cited by 108
Self-citationRecent progress in mass spectrometry-based strategies for elucidating protein–protein interactions
Low, T. Y., Syafruddin, S. E., Mohtar, M. A., Vellaichamy, A., Rahman, N. S. A., Pung, Y. F., & Tan, C. S. H. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03856-0 · Cited by 113
“To simultaneously monitor the dynamics for hundreds to thousands of protein complexes, proteomewide quantification of protein thermal solubility is determined using quantitative MS, similar to that of thermal proteome profiling [88], which employs isobaric TMT (tandem mass tag) reagents to simultaneously quantify prot…”
MethodApplication of omics- and multi-omics-based techniques for natural product target discovery
Zhang, H., Lv, C., Zhang, L., Guo, X., Shen, Y., Nagle, D. G., Zhou, Y., Liu, S., Zhang, W., & Luan, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111833 · Cited by 124
Small-Molecule Target Engagement in Cells
Schürmann, M., Janning, P., Ziegler, S., & Waldmann, H. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.03.008 · Cited by 123
“For the kinase inhibitor GSK3182571, a comparison between pIC50 values (negative decimal logarithm of the half-maximal inhibitory concentration) determined in kinobead assays and pEC50 values (negative decimal logarithm of the half-maximal effective concentration) obtained with the TPP-CCR technique showed a good corr…”
InfluentialPrediction of intracellular exposure bridges the gap between target- and cell-based drug discovery
Mateus, A., Gordon, L. J., Wayne, G. J., Almqvist, H., Axelsson, H., Seashore-Ludlow, B., Treyer, A., Matsson, P., Lundbäck, T., West, A., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701848114 · Cited by 103
“Papp =−ln 1− CA CD · VA ·VD ðVA +VDÞ ·a · t [10]”
The Druggability of Solute Carriers
Wang, W., Gallo, L. H., Jadhav, A. M., Hawkins, R., & Parker, C. G. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01237 · Cited by 115
A Small Molecule that Induces Intrinsic Pathway Apoptosis with Unparalleled Speed
Palchaudhuri, R., Lambrecht, M. J., Botham, R. C., Partlow, K. C., van Ham, T. J., Putt, K. S., Nguyen, L. T., Kim, S.-H., Peterson, R. T., Fan, T. M., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.042 · Cited by 110
“In addition, the pan-kinase inhibition and ever-emerging biological effects elicited by staurosporine (Savitski et al., 2014) complicate interpretation of downstream readouts, as demonstrated by the fact that other proapoptotic agents (e.”
Impact of phosphorylation on thermal stability of proteins
Potel, C. M., Kurzawa, N., Becher, I., Typas, A., Mateus, A., & Savitski, M. M. (2021) · Nature Methods · doi:10.1038/s41592-021-01177-5 · Cited by 103
“2; (3) finding the largest subset of peptides fulfilling these criteria in either of the replicates; (4) fitting a melting curve to the median fold change of the set of selected peptides for each replicate; (5) selecting the replicate yielding the highest R2 value, and obtaining normalization factors for each of the r…”
BackgroundSelf-citationAn isothermal shift assay for proteome scale drug-target identification
Ball, K. A., Webb, K. J., Coleman, S. J., Cozzolino, K., Jacobsen, J. R., Jones, K. R., Stowell, M. H. B., & Old, W. M. (2020) · Communications Biology · doi:10.1038/s42003-020-0795-6 · Cited by 109
Nonparametric Analysis of Thermal Proteome Profiles Reveals Novel Drug-binding Proteins*
Childs, D., Bach, K., Franken, H., Anders, S., Kurzawa, N., Bantscheff, M., Savitski, M. M., & Huber, W. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.tir119.001481 · Cited by 102
Self-citationMiettinen, T. P., Peltier, J., Härtlova, A., Gierliński, M., Jansen, V. M., Trost, M., & Björklund, M. (2018) · The EMBO Journal · doi:10.15252/embj.201798359 · Cited by 101
“The sigmoid curve from Savitski et al (2014), where f 0 is the plateau at temperature T ?”
InfluentialDrug mechanism‐of‐action discovery through the integration of pharmacological and CRISPR screens
Gonçalves, E., Segura‐Cabrera, A., Pacini, C., Picco, G., Behan, F. M., Jaaks, P., Coker, E. A., van der Meer, D., Barthorpe, A., Lightfoot, H., et al. (2020) · Molecular Systems Biology · doi:10.15252/msb.20199405 · Cited by 101
“…of cells, chemical proteomics approaches such as kinobeads (Bantscheff et al , 2007; Me´dard et al , 2015) and cellular thermal shift assay (Savitski et al , 2014) to measure drug – protein interactions, and multiplexed imaging or flow-cytometry to measure multiple cellular parameters upon…”
Photoaffinity labelling strategies for mapping the small molecule–protein interactome
Burton, N. R., Kim, P., & Backus, K. M. (2021) · Organic & Biomolecular Chemistry · doi:10.1039/d1ob01353j · Cited by 114
Know your target, know your molecule
Bunnage, M. E., Gilbert, A. M., Jones, L. H., & Hett, E. C. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1813 · Cited by 107
Covalent Protein Labeling at Glutamic Acids
Martín‐Gago, P., Fansa, E. K., Winzker, M., Murarka, S., Janning, P., Schultz‐Fademrecht, C., Baumann, M., Wittinghofer, A., & Waldmann, H. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.03.015 · Cited by 103
Hashimoto, Y., Sheng, X., Murray-Nerger, L. A., & Cristea, I. M. (2020) · Nature Communications · doi:10.1038/s41467-020-14586-5 · Cited by 100
Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets
Knezevic, C. E., Wright, G., Remsing Rix, L. L., Kim, W., Kuenzi, B. M., Luo, Y., Watters, J. M., Koomen, J. M., Haura, E. B., Monteiro, A. N., et al. (2016) · Cell Chemical Biology · doi:10.1016/j.chembiol.2016.10.011 · Cited by 100
(2020) · doi:10.15252/embj.2019102246 · Cited by 89
“To link the observed phenotypes to changes in protein abundance and activity, we compared an nlpI knockout strain ( Δ nlpI ) to wild-type E. coli using two-dimensional thermal proteome profiling (2D-TPP; Savitski et al , 2014; Mateus et al , 2018).”
Self-citationDeepSTABp: A Deep Learning Approach for the Prediction of Thermal Protein Stability
Jung, F., Frey, K., Zimmer, D., & Mühlhaus, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087444 · Cited by 98
A timeline of stable isotopes and mass spectrometry in the life sciences
Lehmann, W. D. (2016) · Mass Spectrometry Reviews · doi:10.1002/mas.21497 · Cited by 105
Foulkes, D. M., Byrne, D. P., Yeung, W., Shrestha, S., Bailey, F. P., Ferries, S., Eyers, C. E., Keeshan, K., Wells, C., Drewry, D. H., et al. (2018) · Science Signaling · doi:10.1126/scisignal.aat7951 · Cited by 95
Yang, C., Wang, T., Zhao, Y., Meng, X., Ding, W., Wang, Q., Liu, C., & Deng, H. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.06.010 · Cited by 98
Large-scale chemoproteomics expedites ligand discovery and predicts ligand behavior in cells
Offensperger, F., Tin, G., Duran-Frigola, M., Hahn, E., Dobner, S., Ende, C. W. A., Strohbach, J. W., Rukavina, A., Brennsteiner, V., Ogilvie, K., et al. (2024) · Science · doi:10.1126/science.adk5864 · Cited by 94
Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer
Dieter, S. M., Siegl, C., Codó, P. L., Huerta, M., Ostermann-Parucha, A. L., Schulz, E., Zowada, M. K., Martin, S., Laaber, K., Nowrouzi, A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109394 · Cited by 95
CETSA beyond Soluble Targets: a Broad Application to Multipass Transmembrane Proteins
Kawatkar, A., Schefter, M., Hermansson, N.-O., Snijder, A., Dekker, N., Brown, D. G., Lundbäck, T., Zhang, A. X., & Castaldi, M. P. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00399 · Cited by 96
Comprehensive chemical proteomics for target deconvolution of the redox active drug auranofin
Saei, A. A., Gullberg, H., Sabatier, P., Beusch, C. M., Johansson, K., Lundgren, B., Arvidsson, P. I., Arnér, E. S. J., & Zubarev, R. A. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101491 · Cited by 97
“TPP performed in lysate where most protein complexes are disrupted or weakened, can show proteins which directly interact with the compound [1].”
BackgroundMethodTurning liabilities into opportunities: Off-target based drug repurposing in cancer
Palve, V. C., Liao, Y., Rix, L. L. R., & Rix, U. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.02.003 · Cited by 103
Emerging Therapeutic Potential of SIRT6 Modulators
Fiorentino, F., Mai, A., & Rotili, D. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00601 · Cited by 98
Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766)
Chessum, N. E. A., Sharp, S. Y., Caldwell, J. J., Pasqua, A. E., Wilding, B., Colombano, G., Collins, I., Ozer, B., Richards, M., Rowlands, M., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01406 · Cited by 91
Walker, E. J., Bettinger, J. Q., Welle, K. A., Hryhorenko, J. R., & Ghaemmaghami, S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1819851116 · Cited by 90
Martín‐Gago, P., Fansa, E. K., Klein, C. H., Murarka, S., Janning, P., Schürmann, M., Metz, M., Ismail, S., Schultz‐Fademrecht, C., Baumann, M., et al. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201610957 · Cited by 88
Lv, C., Huang, Y., Wang, Q., Wang, C., Hu, H., Zhang, H., Lu, D., Jiang, H., Shen, R., Zhang, W., et al. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2023.02.003 · Cited by 95
CRISPR Approaches to Small Molecule Target Identification
Jost, M., & Weissman, J. S. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.7b00965 · Cited by 88
Cell surface thermal proteome profiling tracks perturbations and drug targets on the plasma membrane
Kalxdorf, M., Günthner, I., Becher, I., Kurzawa, N., Knecht, S., Savitski, M. M., Eberl, H. C., & Bantscheff, M. (2021) · Nature Methods · doi:10.1038/s41592-020-01022-1 · Cited by 98
Self-citationAn overview of kinase downregulators and recent advances in discovery approaches
Wang, B., Wu, H., Hu, C., Wang, H., Liu, J., Wang, W., & Liu, Q. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00826-7 · Cited by 100
“Through subsequent comparison of the changes in protein Tm between vehicle- and drug-treated samples, the approach provides an unbiased evaluation of drug target occupancy for various targets, not just for kinases, facilitating the identification of drug efficacy and toxicity markers.(120,121)Using this strategy, Stef…”
BackgroundInfluentialAdvancing translational research and precision medicine with targeted proteomics
Uzozie, A. C., & Aebersold, R. H. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2018.02.021 · Cited by 99
Plant Chemical Genetics: From Phenotype-Based Screens to Synthetic Biology
Dejonghe, W., & Russinova, E. (2017) · PLANT PHYSIOLOGY · doi:10.1104/pp.16.01805 · Cited by 90
Li, K., Chen, S., Wang, K., Wang, Y., Xue, L., Ye, Y., Fang, Z., Lyu, J., Zhu, H., Li, Y., et al. (2024) · Nature Methods · doi:10.1038/s41592-024-02553-7 · Cited by 102
Ligand discovery by activity-based protein profiling
Niphakis, M. J., & Cravatt, B. F. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.08.006 · Cited by 98
Rutkowska, A., Thomson, D. W., Vappiani, J., Werner, T., Mueller, K. M., Dittus, L., Krause, J., Muelbaier, M., Bergamini, G., & Bantscheff, M. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00346 · Cited by 84
Self-citationDual blockade of the lipid kinase PIP4Ks and mitotic pathways leads to cancer-selective lethality
Kitagawa, M., Liao, P.-J., Lee, K. H., Wong, J., Shang, S. C., Minami, N., Sampetrean, O., Saya, H., Lingyun, D., Prabhu, N., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02287-5 · Cited by 80
Self-citationUechi, H., Sridharan, S., Nijssen, J., Bilstein, J., Iglesias-Artola, J. M., Kishigami, S., Casablancas-Antras, V., Poser, I., Martinez, E. J., Boczek, E., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/721001 · Cited by 82
Self-citationData, Reagents, Assays and Merits of Proteomics for SARS-CoV-2 Research and Testing
Zecha, J., Lee, C., Bayer, F. P., Meng, C., Grass, V., Zerweck, J., Schnatbaum, K., Michler, T., Pichlmair, A., Ludwig, C., et al. (2020) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra120.002164 · Cited by 85
Reznik, E., Christodoulou, D., Goldford, J. E., Briars, E. A., Sauer, U., Segrè, D., & Noor, Ε. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.066 · Cited by 89
Target deconvolution from phenotype-based drug discovery by using chemical proteomics approaches
Kubota, K., Funabashi, M., & Ogura, Y. (2018) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2018.08.002 · Cited by 88
Recent advances in isobaric labeling and applications in quantitative proteomics
Sivanich, M. K., Gu, T., Tabang, D. N., & Li, L. (2022) · PROTEOMICS · doi:10.1002/pmic.202100256 · Cited by 82
“TPP is based off CETSA where cells are treated either in vivo or extracted with subsequent heat perturbation and then labeled with isobaric tags for multiplexed quantitative mass spectrometry as illustrated in Figure 5 [130] Thermal shift curves are created from normalization of reporter ion intensities and complex pr…”
MethodTolvanen, T. A. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.866764 · Cited by 88
“With MS, the melting behavior of the whole proteome, sometimes referred to as meltome, of the sample is investigated in one go (Savitski et al., 2014).”
BackgroundMethodMakowski, M. M., Gräwe, C., Foster, B. M., Nguyen, N. V., Bartke, T., & Vermeulen, M. (2018) · Nature Communications · doi:10.1038/s41467-018-04084-0 · Cited by 79
Lysine-specific demethylase 1A restricts ex vivo propagation of human HSCs and is a target of UM171
Subramaniam, A., Žemaitis, K., Talkhoncheh, M. S., Yudovich, D., Bäckström, A., Debnath, S., Chen, J., Jain, M. V., Galeev, R., Gaetani, M., et al. (2020) · Blood · doi:10.1182/blood.2020005827 · Cited by 75
ProTargetMiner as a proteome signature library of anticancer molecules for functional discovery
Saei, A. A., Beusch, C. M., Chernobrovkin, A. L., Sabatier, P., Zhang, B., Güler, Ü., Stergiou, E., Gaetani, M., Végvári, Á., & Zubarev, R. A. (2019) · Nature Communications · doi:10.1038/s41467-019-13582-8 · Cited by 83
A Primer on Concepts and Applications of Proteomics in Neuroscience
Hosp, F., & Mann, M. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.025 · Cited by 84
Importance of Quantifying Drug-Target Engagement in Cells
Stefaniak, J., & Huber, K. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00570 · Cited by 83
Kaur, U., He, M., Lui, F., Ma, R., Ogburn, R. N., Johnson, J. H. R., Fitzgerald, M. C., & Jones, L. M. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00341 · Cited by 77
Chemoproteomic methods for covalent drug discovery
Chan, W. C., Sharifzadeh, S., Buhrlage, S. J., & Marto, J. A. (2021) · Chemical Society Reviews · doi:10.1039/d1cs00231g · Cited by 83
Benchmarking the Orbitrap Tribrid Eclipse for Next Generation Multiplexed Proteomics
Yu, Q., Paulo, J. A., Navarrete-Perea, J., McAlister, G. C., Canterbury, J. D., Bailey, D. J., Robitaille, A. M., Huguet, R., Zabrouskov, V., Gygi, S. P., et al. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.9b05685 · Cited by 79
Genetic screens reveal a central role for heme metabolism in artemisinin susceptibility
Harding, C. R., Sidik, S. M., Petrova, B., Gnädig, N. F., Okombo, J., Herneisen, A. L., Ward, K. E., Markus, B. M., Boydston, E. A., Fidock, D. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18624-0 · Cited by 73
Lee, P. Y., Yeoh, Y., & Low, T. Y. (2022) · FEBS Journal · doi:10.1111/febs.16442 · Cited by 84
Assessing target engagement using proteome-wide solvent shift assays
Vranken, J. G. V., Li, J., Mitchell, D. C., Navarrete-Perea, J., & Gygi, S. P. (2021) · eLife · doi:10.7554/elife.70784 · Cited by 75
“70784 13 of 21 The solvent shift assays introduced here echo many important features of proteomewide thermal shift assays—TPP and thermalPISA (Gaetani et al., 2019; Savitski et al., 2014).”
BackgroundMethodInfluentialTong, K., Lok, C., Wan, P., Hu, D., Fung, Y. M. E., Chang, X., Huang, S., Jiang, H., & Che, C. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1915202117 · Cited by 196
“Thermal proteome profiling was performed by bottom-up proteomic analysis of tandem mass tag (TMT)-labeled peptides from trypsin-digested proteins using an Orbitrap Fusion Tribrid mass spectrometer (Thermo Scientific) (42).”
MethodInfluentialFunctional genomics to uncover drug mechanism of action
Nijman, S. M. B. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1963 · Cited by 78
Prediction and collection of protein–metabolite interactions
Zhao, T., Liu, J., Zeng, X., Wang, W., Li, S., Zang, T., Peng, J., & Yang, Y. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab014 · Cited by 77
Proteomics in Drug Development: The Dawn of a New Era?
Frantzi, M., Latosińska, A., & Mischak, H. (2019) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201800087 · Cited by 79
Zhu, J., Singh, M., Selivanova, G., & Peuget, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-58051-1 · Cited by 80
Integrating knowledge and omics to decipher mechanisms via large‐scale models of signaling networks
Garrido‐Rodriguez, M., Zirngibl, K., Ivanova, O., Lobentanzer, S., & Saez‐Rodriguez, J. (2022) · Molecular Systems Biology · doi:10.15252/msb.202211036 · Cited by 70
“…to single-cell technologies, novel untargeted proteomic approaches like limited proteolysis proteomics (Feng et al , 2014) and thermal proteome profiling proteomics (Savitski et al , 2014) allow us to estimate different types of regulatory events by measuring protein conformational changes.”
Fluorescence anisotropy imaging in drug discovery
Vinegoni, C., Feruglio, P. F., Gryczyński, I., Mazitschek, R., & Weissleder, R. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.019 · Cited by 81
“target binding of thousands of proteins using mass spectrometry [8].”
Small-Molecule Kinase Downregulators
Jones, L. H. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.10.011 · Cited by 71
“Interestingly, a promiscuous kinase inhibitor was shown recently to destabilize CHK1 in a cellular thermal shift assay (CETSA) (Savitski et al., 2014).”
BackgroundPan, S., Ding, A., Li, Y., Sun, Y., Zhan, Y., Ye, Z., Song, N., Peng, B., Li, L., Huang, W., et al. (2023) · Chemical Society Reviews · doi:10.1039/d3cs00056g · Cited by 74
Gorshkov, V., Bubis, J. A., Solovyeva, E. M., Gorshkov, M. V., & Kjeldsen, F. (2019) · Environmental Science Nano · doi:10.1039/c8en01054d · Cited by 88
Quantifying Target Occupancy of Small Molecules Within Living Cells
Robers, M. B., Ohana, R. F., Huber, K., Kilpatrick, L. E., Vasta, J. D., Berger, B., Chaudhry, C., Hill, S. J., Müller, S., Knapp, S., et al. (2020) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-011420-092302 · Cited by 75
“In contrast with thermal proteome profiling of dasatinib [which did not identify Abl or BCR-Abl (90)], each probe displacement method identified established targets of dasatinib, including Abl and various tyrosine kinases.”
BackgroundAdvanced Techniques for Detecting Protein Misfolding and Aggregation in Cellular Environments
Bai, Y., Zhang, S., Dong, H. Y., Liu, Y., Liu, C., & Zhang, X. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00494 · Cited by 77
Kirsch, V. C., Orgler, C., Braig, S., Jeremias, I., Auerbach, D., Müller, R., Vollmar, A. M., & Sieber, S. A. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201911158 · Cited by 76
Drug Target Identification in Tissues by Thermal Proteome Profiling
Mateus, A., Kurzawa, N., Perrin, J., Bergamini, G., & Savitski, M. M. (2021) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-052120-013205 · Cited by 73
Self-citationComputer-Aided Drug Discovery for Undruggable Targets
Sun, Q., Wang, H., Xie, J., Wang, L., Mu, J., Li, J., Ren, Y., & Lai, L. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00969 · Cited by 82
System-wide identification and prioritization of enzyme substrates by thermal analysis
Saei, A. A., Beusch, C. M., Sabatier, P., Astorga‐Wells, J., Gharibi, H., Meng, Z., Chernobrovkin, A. L., Rodin, S., Näreoja, K., Thorsell, A. G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21540-6 · Cited by 72
PROTAC technology as a novel tool to identify the target of lathyrane diterpenoids
Wu, Y., Yang, Y., Wang, W., Sun, D., Zheng, M., Zhou, Y., Li, H., Zhu, M., Li, H., & Chen, L. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.07.007 · Cited by 69
“target proteins’ susceptibility to proteolysis or thermal denaturation [67,68].”
BackgroundTargeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors
Azimi, A., Caramuta, S., Seashore-Ludlow, B. A., Boström, J., Robinson, J. L., Edfors, F., Tuominen, R., Kemper, K., Krijgsman, O., Peeper, D. S., et al. (2018) · Molecular Systems Biology · doi:10.15252/msb.20177858 · Cited by 72
“We first investigated the binding partners of XL888 in SK-Mel 24 and SK-Mel 28 cells using thermal proteome profiling (TPP; Martinez Molina et al , 2013; Savitski et al , 2014).”
Monitoring and deciphering protein degradation pathways inside cells
Daniels, D. L., Riching, K. M., & Urh, M. (2019) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2018.12.001 · Cited by 67
Sample Preparation for Mass Spectrometry-Based Proteomics; from Proteomes to Peptides
ROGERS, J. C., & Bomgarden, R. D. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-41448-5_3 · Cited by 74
Wang, Q., Wang, J., Yu, D., Zhang, Q., Hu, H., Xu, M., Zhang, H., Tian, S., Zheng, G., Lu, D., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101357 · Cited by 97
Comess, K. M., McLoughlin, S. M., Oyer, J. A., Richardson, P. L., Stöckmann, H., Vasudevan, A., & Warder, S. E. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01921 · Cited by 71
Friman, T. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.115174 · Cited by 71
He, M., Ma, R., & Fitzgerald, M. C. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b01772 · Cited by 67
Laraia, L., Garivet, G., Foley, D. J., Kaiser, N., Müller, S., Zinken, S., Pinkert, T., Wilke, J., Corkery, D., Pahl, A., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201913712 · Cited by 71
Cichonska, A., Rousu, J., & Aittokallio, T. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1096926 · Cited by 65
“devised a more general approach for proteome-wide monitoring of protein--ligand binding directly in living cells by combining the technique of cellular thermal shift assay with quantitative mass spectrometry (MS) [28].”
MethodHigh-Throughput Cellular Thermal Shift Assays in Research and Drug Discovery
Henderson, M. J., Holbert, M. A., Simeonov, A. M., & Kallal, L. A. (2019) · SLAS DISCOVERY · doi:10.1177/2472555219877183 · Cited by 72
“We readily admit that not all target classes are amenable to CETSA screening, but there is experimental evidence that more than 5000 proteins have quantifiable melting profiles in K562 cells, which provides validation that HT-CETSA screening is feasible for a subset of the human proteome.(11) For proteins that are not…”
BackgroundChemoproteomic mapping of the glycolytic targetome in cancer cells
Tian, Y., Wan, N., Zhang, H., Shao, C., Ding, M., Bao, Q., Hu, H., Sun, H., Liu, C., Zhou, K., et al. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01355-w · Cited by 68
“In addition to TPP and CETSA, limited proteolysis–small-molecule mapping (LiP–SMap) is another widely used, derivatization-free chemoproteomic approach enabling target discovery 6 .”
MethodDehghan, E., Goodarzi, M., Saremi, B., Lin, R., & Mirzaei, H. (2019) · Nature Communications · doi:10.1038/s41467-019-12425-w · Cited by 69
Mass spectrometry analysis of the structural proteome
de Souza, N., & Picotti, P. (2019) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2019.10.006 · Cited by 63
Systematic mapping of protein‐metabolite interactions in central metabolism of Escherichia coli
Diether, M., Nikolaev, Y., Allain, F. H. ‐., & Sauer, U. (2019) · Molecular Systems Biology · doi:10.15252/msb.20199008 · Cited by 62
“…available high-throughput methods do not detect metabolite binding itself, but instead measure indirect interaction consequences on the protein (Savitski et al, 2014; Diether & Sauer, 2017; Piazza et al, 2018), thus missing interactions that elicit only weak effects or are 1 Institute of…”
BackgroundMethodChemical proteomics reveals target selectivity of clinical Jak inhibitors in human primary cells
Eberl, H. C., Werner, T., Reinhard, F. B. M., Lehmann, S., Thomson, D. W., Chen, P., Zhang, C., Rau, C., Muelbaier, M., Drewes, G., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50335-5 · Cited by 69
Self-citationChemoproteomic-enabled phenotypic screening
Conway, L. P., Li, W., & Parker, C. G. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.01.012 · Cited by 63
Li, J.-M., Deng, H., Yao, Y.-D., Wang, W., Hu, J.-Q., Dong, Y., Wang, P., Liu, L., Liu, Z., Xie, Y., et al. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01124-4 · Cited by 65
Byrne, D. P., Vonderach, M., Ferries, S., Brownridge, P. J., Eyers, C. E., & Eyers, P. A. (2016) · Biochemical Journal · doi:10.1042/bcj20160648 · Cited by 60
Bioactive Compound Collections: From Design to Target Identification
Laraia, L., Robke, L., & Waldmann, H. (2018) · Chem · doi:10.1016/j.chempr.2018.01.012 · Cited by 65
“problem, thermal proteome profiling (TPP) was developed (Figure 19).(86) Originally intended as a target validation strategy for showing target engagement in cell lysates, it is now increasingly being used in the target ID process.”
MethodAnticancer Effect of Deuterium Depleted Water - Redox Disbalance Leads to Oxidative Stress
Zhang, X., Gaetani, M., Chernobrovkin, A. L., & Zubarev, R. A. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001455 · Cited by 61
“After labeling using TMT-10 reagent, desalting with C18 Sep-pak columns and fractionation by a high pH kit as above, the 10 fractions of peptides for each sample were analyzed by nanoLC-MS/MS. NanoLC-MS/MS Analysis—NanoLC-MS/MS analyses of FITExP and TPP samples were performed on a Q Exactive HF mass spectrometer, and…”
MethodInfluential
Metadata
- Authors
- Savitski, M. M., Reinhard, F. B. M., Franken, H., Werner, T., Savitski, M. F., Eberhard, D., Molina, D. M., Jafari, R., Dovega, R. B., Klaeger, S., Kuster, B., Nordlund, P., Bantscheff, M., & Drewes, G.
- Affiliations
- GlaxoSmithKline (Germany) (DE)
- Karolinska Institutet (SE)
- German Cancer Research Center (DE)
- Department of Proteomics and Bioanalytics, Technische Universität München, Emil Erlenmeyer Forum 5, Freising, Germany.
- Division of Biophysics, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
- Corresponding author
- Savitski, Mikhail M.
- Reinhard, Friedrich B. M.
- Bantscheff, Marcus
- Drewes, Gerard
- ORCID
- Venue
- Science
- Published
- 2014-10-03
- Volume
- 346
- Issue
- 6205
- Pages
- 1255784-1255784
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2131321938
- Cited by
- 1,187
- References
- 41
- Citations by year
- 2026: 119 · 2025: 138 · 2024: 148 · 2023: 130 · 2022: 116 · 2021: 132 · 2020: 95 · 2019: 85 · 2018: 67 · 2017: 56 · 2016: 54 · 2015: 39 · 2014: 5
- FWCI
- 22.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Physical Sciences › Chemistry › Physical and Theoretical Chemistry › thermodynamics and calorimetric analyses
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Keywords
- thermal proteome profiling, drug-target engagement, protein thermal stability, kinase inhibitors, staurosporine, ferrochelatase, vemurafenib, alectinib, phototoxicity, dasatinib, BCR-ABL, cancer drug targets
- MeSH terms
- Adenosine Triphosphatases, Antineoplastic Agents, Hot Temperature, Humans, Ligands, Protein Binding, Protein Denaturation, K562 Cells, Proteome, Proteomics, Protein Stability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.